Sizing up how the end of 2023 was for restaurants
https://www.nrn.com/first-bite/sizing-how-end-2023-was-restaurants
Jan 04, 2024 - Consumers said they were going to dine out during the holidays, and recently released data indicates they did just that.
A National Restaurant Association survey from early December showed that 63% of adults planned to eat out during the s
0
Allstate (ALL) Up 29% in 6 Months: What's Ahead for Investors?
https://www.zacks.com/stock/news/2205237/allstate-all-up-29-in-6-months-what-s-ahead-for-investors?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2205237
Jan 03, 2024 - Allstate (ALL) remains well-poised for growth on improved P&C insurance premiums, acquisitions and sufficient cash-generating abilities.
0
Dry January may help improve your finances. One woman has already saved $48,000 by giving up alcohol
https://www.cnbc.com/2024/01/03/how-dry-january-can-help-you-save-money-improve-health.html
Jan 03, 2024 - If you're on the fence about partaking in Dry January, there's an incentive to consider: the financial savings.
0
Piper Sandler raises Teva to neutral, stock up 4%
https://seekingalpha.com/news/4052045-piper-sandler-raises-teva-to-neutral-stock-climbs?source=feed_sector_healthcare
Jan 03, 2024 - Piper Sandler has upgraded Teva (TEVA) to neutral, citing the company’s efforts to lower its debt and “lean into its brand assets." The investment bank added, h
0
Limbach (LMB) Is Up 1.84% in One Week: What You Should Know
https://www.zacks.com/stock/news/2205162/limbach-lmb-is-up-1-84-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2205162
Jan 03, 2024 - Does Limbach (LMB) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Longboard Pharma (LBPH) Up on Upbeat Data From Epilepsy Study
https://www.zacks.com/stock/news/2204966/longboard-pharma-lbph-up-on-upbeat-data-from-epilepsy-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2204966
Jan 03, 2024 - Longboard Pharma (LBPH) skyrockets 316% on positive data from phase Ib/IIa study of bexicaserin for the treatment of seizures associated with a broad range of epilepsy indications.
0
Daktronics: Fast Growth, But The Order Backlog Is Drying Up
https://seekingalpha.com/article/4660847-daktronics-fast-growth-but-the-order-backlog-is-drying-up?source=feed_all_articles
Jan 02, 2024 - Daktronics' revenues and net income have been growing rapidly since FY22 and the forecasts for global LED video display market are bright. Read more on DAKT here.
0
Journey Medical secures credit facility for up to $20M
https://seekingalpha.com/news/4051721-journey-medical-secures-credit-facility-for-up-to-20m?source=feed_sector_healthcare
Jan 02, 2024 - Journey Medical secures credit facility with SWK Holdings, allowing for borrowings of up to $20M to fund corporate operations and product development.
0
HSBC Wraps Up Sale of France-Based Retail Banking Business
https://www.zacks.com/stock/news/2204418/hsbc-wraps-up-sale-of-france-based-retail-banking-business?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2204418
Jan 02, 2024 - HSBC completes the divestiture of its French retail banking business. The company will continue to provide wealth and private banking businesses in the country.
0
Singapore GDP Growth Picks Up In Q4
https://www.rttnews.com/3414145/singapore-gdp-growth-picks-up-in-q4.aspx?type=alleco
Jan 02, 2024 - Singapore's economy expanded at a faster pace in the fourth quarter on the back of growth in manufacturing and construction output but a less favorable external environment poses risks to the outlook. Gross domestic product grew 2.8 percent annually, following the 1.0 percent expansion in the preceding period, advance estimates from the Ministry of Trade and Industry showed on Tuesday.
0